4 ASX stocks hammered down by the market today

All Ordinaries manages a rare positive day, rising 0.2%, but that didn't help these 4 stocks

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In what seems a rare occasion these days, the All Ordinaries (Index: ^AORD) (ASX: XAO) has managed to post a 0.2% rise on the ASX today.

But that didn't help these four stocks, which were heavily sold off…

Education provider Vocation Ltd (ASX: VET) dropped 15.1% to 22.5 cents, and has now lost 89% in the past year. But the market may have oversold the company – as we discussed earlier today. At these prices, the company is trading on just over two times 2015 financial year earnings before interest, tax, depreciation and amortisation (EBITDA), expected to be between $25 million and $30 million. Total market cap is $61 million.

Travel agent Helloworld Ltd (ASX: HLO) sank 11.8% to 30 cents, but shares did jump as much as 50% last week to 39 cents, after the company announced that it had been appointed as the sole provider of travel management services to the Australian government. It may simply be a case of long time shareholders taking the opportunity to jump out of the stock, which once traded above $3.70.

Mining services company Boart Longyear Limited (ASX: BLY) fell 11.1% to 16 cents, after the company said demand for its drilling services was unlikely to rise in the next twelve months. Boart has managed to recapitalise itself, but heavy exposure to copper and gold exploration mean the company is not out of the woods yet. CEO Richard O'Brien says exploration for those two metals continues to dry up.

Junior biotech Novagen Limited (ASX: NRT) dropped 30% to 11.5 cents, after rising 96% yesterday, and adding 63% earlier today. It's certainly been a rollercoaster for shareholders, after the company announced it had made a breakthrough in the treatment of melanoma, and then capitalising on the rocketing share price, announced a capital raising.

Motley Fool writer/analyst Mike King doesn't own shares in any stocks mentioned. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »